UCB and Biogen revealed that their Phase 3 study testing dapirolizumab pegol in people with systemic lupus erythematosus met ...
The series B fundraising will support the clinical development of next-generation multivalent vaccines against respiratory ...
Although vaccines already exist to prevent mpox, high prices and the risk of side effects make it difficult to roll them out ...
Dandelion Health used its new clinical AI marketplace to analyze real-world data, showing that GLP-1 drugs may help prevent ...
The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...
Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...
Aurora Biosynthetics has launched in Australia as a subsidiary of Myeloid Therapeutics, a US-based biotech focusing on cancer immunotherapy. Myeloid uses lipid nanoparticles to deliver mRNA molecules ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback